Institut d'hématologie et d'oncologie pédiatrique

Lyon 69008

0 studies enrolling now · 1 studies all time

What they study most

Acute Myeloid Leukemia (AML)

Studies at this site

• Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML — Stopped early